These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30835327)

  • 1. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ
    Cardiol J; 2019; 26(2):147-156. PubMed ID: 30835327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
    JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
    Samuel TY; Hasin T; Gotsman I; Weitzman T; Ben Ivgi F; Dadon Z; Asher E; Amir O; Glikson M; Alcalai R; Leibowitz D
    Drugs R D; 2022 Mar; 22(1):25-33. PubMed ID: 34826125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.
    Mortensen SA
    Biofactors; 2003; 18(1-4):79-89. PubMed ID: 14695923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double-blind, placebo-controlled trial.
    Voors AA; Bax JJ; Hernandez AF; Wirtz AB; Pap AF; Ferreira AC; Senni M; van der Laan M; Butler J;
    Eur J Heart Fail; 2019 Nov; 21(11):1426-1433. PubMed ID: 31523892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.
    Cunningham JW; Ferreira JP; Deng H; Anker SD; Byra WM; Cleland JGF; Gheorghiade M; Lam CSP; La Police D; Mehra MR; Neaton JD; Spiro TE; van Veldhuisen DJ; Greenberg B; Zannad F
    JACC Heart Fail; 2020 May; 8(5):359-368. PubMed ID: 32171760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?
    Oleck S; Ventura HO
    Curr Heart Fail Rep; 2016 Aug; 13(4):190-5. PubMed ID: 27333901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial.
    Docherty KF; Jhund PS; Claggett B; Ferreira JP; Bengtsson O; Inzucchi SE; Køber L; Kosiborod MN; Langkilde AM; Martinez FA; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; McMurray JJV;
    JAMA Cardiol; 2021 Nov; 6(11):1298-1305. PubMed ID: 34319398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
    Lei L; Liu Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
    Berman M; Erman A; Ben-Gal T; Dvir D; Georghiou GP; Stamler A; Vered Y; Vidne BA; Aravot D
    Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-Pro BNP Predicts Myocardial Injury Post-vascular Surgery and is Reduced with CoQ
    Khan A; Johnson DK; Carlson S; Hocum-Stone L; Kelly RF; Gravely AA; Mbai M; Green DL; Santilli S; Garcia S; Adabag S; McFalls EO
    Ann Vasc Surg; 2020 Apr; 64():292-302. PubMed ID: 31629852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
    J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of coenzyme Q10 supplementation on diastolic function in patients with heart failure with preserved ejection fraction.
    Sobirin MA; Herry Y; Sofia SN; Uddin I; Rifqi S; Tsutsui H
    Drug Discov Ther; 2019; 13(1):38-46. PubMed ID: 30880321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 and Heart Failure: A State-of-the-Art Review.
    Sharma A; Fonarow GC; Butler J; Ezekowitz JA; Felker GM
    Circ Heart Fail; 2016 Apr; 9(4):e002639. PubMed ID: 27012265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.
    Alehagen U; Johansson P; Björnstedt M; Rosén A; Dahlström U
    Int J Cardiol; 2013 Sep; 167(5):1860-6. PubMed ID: 22626835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.